Covered recipient · General Payments record
DAVID L JOHN
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$1,271.47
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.48 | 20 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $278.09 | 16 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $45.21 | 2 |
| Acerta Pharma LLC | $31.13 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $22.43 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117288097 | CMS |
| Amgen Inc. | $25.22 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111610097 | CMS |
| Amgen Inc. | $22.60 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111610099 | CMS |
| Amgen Inc. | $3.51 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111610101 | CMS |
| Amgen Inc. | $4.58 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111610103 | CMS |
| Amgen Inc. | $7.66 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111610105 | CMS |
| Amgen Inc. | $30.01 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111610107 | CMS |
| Amgen Inc. | $24.91 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111610109 | CMS |
| Amgen Inc. | $11.78 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111610111 | CMS |
| Amgen Inc. | $26.86 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111610113 | CMS |
| Amgen Inc. | $3.73 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111610093 | CMS |
| Amgen Inc. | $27.73 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111610095 | CMS |
| Amgen Inc. | $26.93 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117288089 | CMS |
| Amgen Inc. | $15.43 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117288091 | CMS |
| Amgen Inc. | $20.26 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117288093 | CMS |
| Amgen Inc. | $4.45 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117288095 | CMS |
| AstraZeneca Pharmaceuticals LP | $31.13 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105565232 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.05 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118060537 | CMS |
| Novartis Pharmaceuticals Corporation | $21.86 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087139278 | CMS |
| Novartis Pharmaceuticals Corporation | $23.35 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087139290 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.